QQ客服 官方微博 反馈留言

	Notch pathway inhibition using DAPT, a gamma-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma
	Dai, Guo; Deng, Shuang; Guo, Weichun; Yu, Ling; Yang, Jian; Zhou, Sheng; Gao, Tian
刊名	MOLECULAR CARCINOGENESIS
	2019
卷号	58期号:1
关键词	cancer stem cell chemoresistance combination therapy Notch signaling pathway osteosarcoma (OS)
ISSN号	0899-1987
DOI	10.1002/mc.22873
URL标识	查看原文
收录类别	SCIE
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4233988
专题	武汉大学
推荐引用方式 GB/T 7714	Dai, Guo,Deng, Shuang,Guo, Weichun,et al. Notch pathway inhibition using DAPT, a gamma-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma[J]. MOLECULAR CARCINOGENESIS,2019,58(1).
APA	Dai, Guo.,Deng, Shuang.,Guo, Weichun.,Yu, Ling.,Yang, Jian.,...&Gao, Tian.(2019).Notch pathway inhibition using DAPT, a gamma-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.MOLECULAR CARCINOGENESIS,58(1).
MLA	Dai, Guo,et al."Notch pathway inhibition using DAPT, a gamma-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma".MOLECULAR CARCINOGENESIS 58.1(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。